During the past decade, Prism Clinical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Prism Clinical Research" are "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Adrenal Gland Disease" (1 trials), "Adrenal Hyperplasia" (1 trials), "Adrenocortical Hyperfunction" (1 trials) and "Congenital Adrenal Hyperplasia" (1 trials). Many other conditions were trialed in "Prism Clinical Research" in a lesser frequency.

Most popular intervention types in "Prism Clinical Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "HU6" (2 trials), "Placebo" (1 trials), "Standard glucocorticoid therapy" (1 trials) and "Subcutaneous hydrocortisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prism Clinical Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Prism Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Prism Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prism Clinical Research, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".